Insulin Detemir Versus Insulin NPH: A Randomized Prospective Study Comparing Glycemic Control in Pregnant Women With Diabetes

Trial Profile

Insulin Detemir Versus Insulin NPH: A Randomized Prospective Study Comparing Glycemic Control in Pregnant Women With Diabetes

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2017

At a glance

  • Drugs Insulin aspart (Primary) ; Insulin detemir (Primary) ; Insulin suspension isophane
  • Indications Gestational diabetes; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jun 2015 Primary endpoint of mean blood glucose has not been met, according to results published in the American Journal of Obstetrics and Gynecology. (Although the primary endpoint met clinically, statistical significant difference did not achieve (p=0.2937)).
    • 09 Jun 2015 Results published in the American Journal of Obstetrics and Gynecology.
    • 09 Jun 2015 Status changed from recruiting to completed according to results published in the American Journal of Obstetrics and Gynecology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top